NYSE · Healthcare
Cigna Group (CI)
As-reported financials and recent SEC filings for Cigna Group, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$274.90B
Net income
$5.96B
Net margin
2.2%
Diluted EPS
$22.18
ROE
14.2%
P/E (TTM)
11.9×
Market cap
$78.83B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Gross profit | — | — | — | — | — |
| Operating income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B |
| Net income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| Diluted EPS | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-03
View on EDGAR →42026-06-02
View on EDGAR →42026-05-14
View on EDGAR →8-K2026-05-13
View on EDGAR →1442026-05-12
View on EDGAR →10-Q2026-04-30
View on EDGAR →8-K2026-04-30
View on EDGAR →SCHEDULE 13G2026-04-29
View on EDGAR →Go deeper on CI
Search Cigna Group’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.